These results strongly indicated that application of AAV-sh-Atp6v1c1 gene therapy locally can inhibit alveolar bone loss and tissue damage in periodontitis lesion areas, and may be a promising new strategy for treating periodontal diseases. This evidence concerns the gene ATP6V1C1 and periodontal disorder.